[go: up one dir, main page]

MX2020004110A - Factor estimulante de colonias de granulocito-macrofago (gm-csf) para tratar infecciones refractarias por micobacterias no tuberculosas. - Google Patents

Factor estimulante de colonias de granulocito-macrofago (gm-csf) para tratar infecciones refractarias por micobacterias no tuberculosas.

Info

Publication number
MX2020004110A
MX2020004110A MX2020004110A MX2020004110A MX2020004110A MX 2020004110 A MX2020004110 A MX 2020004110A MX 2020004110 A MX2020004110 A MX 2020004110A MX 2020004110 A MX2020004110 A MX 2020004110A MX 2020004110 A MX2020004110 A MX 2020004110A
Authority
MX
Mexico
Prior art keywords
csf
refractory non
treating refractory
tuberculous mycobacteria
mycobacteria infections
Prior art date
Application number
MX2020004110A
Other languages
English (en)
Inventor
Inge Tarnow
Cecilia Ganslandt
Mark E Wylam
Original Assignee
Drugrecure Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Drugrecure Aps filed Critical Drugrecure Aps
Publication of MX2020004110A publication Critical patent/MX2020004110A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

La presente invención se refiere a métodos para tratar individuos que padecen de una infección pulmonar por NTM refractaria a tratamiento, por ejemplo, a tratamiento con antibióticos.
MX2020004110A 2017-10-16 2018-10-16 Factor estimulante de colonias de granulocito-macrofago (gm-csf) para tratar infecciones refractarias por micobacterias no tuberculosas. MX2020004110A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762572711P 2017-10-16 2017-10-16
EP17198938 2017-10-27
PCT/EP2018/078214 WO2019076883A1 (en) 2017-10-16 2018-10-16 GM-CSF FOR THE TREATMENT OF NON-TUBERCULAR REFRACTORY MYCOBACTERIAL INFECTIONS

Publications (1)

Publication Number Publication Date
MX2020004110A true MX2020004110A (es) 2020-11-06

Family

ID=63840864

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020004110A MX2020004110A (es) 2017-10-16 2018-10-16 Factor estimulante de colonias de granulocito-macrofago (gm-csf) para tratar infecciones refractarias por micobacterias no tuberculosas.

Country Status (8)

Country Link
US (1) US11938169B2 (es)
EP (1) EP3697432A1 (es)
JP (2) JP7545893B2 (es)
KR (1) KR102782058B1 (es)
BR (1) BR112020007395A2 (es)
CA (1) CA3079117A1 (es)
MX (1) MX2020004110A (es)
WO (1) WO2019076883A1 (es)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235871A (en) 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4501728A (en) 1983-01-06 1985-02-26 Technology Unlimited, Inc. Masking of liposomes from RES recognition
US5391485A (en) 1985-08-06 1995-02-21 Immunex Corporation DNAs encoding analog GM-CSF molecules displaying resistance to proteases which cleave at adjacent dibasic residues
US4837028A (en) 1986-12-24 1989-06-06 Liposome Technology, Inc. Liposomes with enhanced circulation time
WO2008052567A2 (en) 2006-11-03 2008-05-08 Drugrecure Aps Enhancing pulmonary host defense via administration of granulocyte-macrophage colony stimulating factor
EP3662924A1 (en) * 2014-03-07 2020-06-10 Reponex Pharmaceuticals A/S Compositions for treating lung infections by airway administration
ES2926985T3 (es) 2014-05-15 2022-10-31 Insmed Inc Métodos para tratar infecciones pulmonares micobacterianas no tuberculosas
JP2019500318A (ja) * 2015-11-18 2019-01-10 インスメッド インコーポレイテッド 細菌感染症を治療するための組成物及び方法

Also Published As

Publication number Publication date
WO2019076883A1 (en) 2019-04-25
JP2020536973A (ja) 2020-12-17
BR112020007395A2 (pt) 2020-09-29
KR20200100603A (ko) 2020-08-26
KR102782058B1 (ko) 2025-03-17
EP3697432A1 (en) 2020-08-26
US20200237869A1 (en) 2020-07-30
CA3079117A1 (en) 2019-04-25
JP7545893B2 (ja) 2024-09-05
US11938169B2 (en) 2024-03-26
JP2024059779A (ja) 2024-05-01

Similar Documents

Publication Publication Date Title
MX394380B (es) Compuestos dinucleótidos cíclicos para eltratamiento de cáncer
MX2023003461A (es) Tratamiento de infeccion por clostridium difficile.
EA201891200A1 (ru) Композиции, содержащие бактериальные штаммы
CL2017000285A1 (es) Terapia combinada para el tratamiento de un paramixovirus
EA201891202A1 (ru) Композиции, содержащие бактериальные штаммы
EA201891201A1 (ru) Композиции, содержащие бактериальные штаммы
EA201890050A1 (ru) Композиции, содержащие бактериальные штаммы
EA201890049A1 (ru) Композиции, содержащие бактериальные штаммы
MX2020003581A (es) Compuestos monobactamicos cromanos para el tratamiento de infecciones bacterianas.
CY1122805T1 (el) Ενωσεις και μεθοδοι για την αγωγη βακτηριακων λοιμωξεων
BR112017001162A2 (pt) métodos para tratar paramixovírus
MX2023004969A (es) Metodos para tratar y prevenir infeccion por c. difficile.
EP4327876A3 (en) Immunogenic compositions
EA201791530A1 (ru) НОВЫЕ N-АЦИЛАРИЛСУЛЬФОНАМИДНЫЕ ПРОИЗВОДНЫЕ В КАЧЕСТВЕ ИНГИБИТОРОВ АМИНОАЦИЛ-тРНК СИНТЕТАЗЫ
PH12017501879A1 (en) Methods for treating cancer
EP4268897A3 (en) Minocycline compounds for biodefense
TN2021000092A1 (en) Antibiotic compounds, methods of manufacturing the same, pharmaceutical compositions containing the same and uses thereof
LT3630111T (lt) Junginiai ir būdai, skirti bakterinių infekcijų gydymui
MX2020012990A (es) Formulaciones de tegavivint y compuestos relacionados.
EA201690227A1 (ru) Азаиндольные соединения, их получение и способы их применения
GEP20247590B (en) Antibacterial quinolines
MX2020004110A (es) Factor estimulante de colonias de granulocito-macrofago (gm-csf) para tratar infecciones refractarias por micobacterias no tuberculosas.
WO2019070709A8 (en) Compounds for treating or preventing flavivirus infections
EP4389222A3 (en) Methods and compositions for the treatment of hepatitis b infection
MX373853B (es) Composiciones antibacterianas y metodos.